TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 3.535
-0.215 (-5.73%)
Oct 9, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 1.36 billion as of October 9, 2026. It is the 21,835th most valuable company in the world and the 1,022nd biggest in Hong Kong. Its market cap has decreased by 79.58% in one year.
Market Cap
1.36B
Enterprise Value
1.30B
Revenue
n/a
Global Rank
Country Rank
#1,022 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 1.36B, a decrease of -73.23%. That is a compound annual growth rate of -46.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.36B | -72.71% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PegBio | 1.83B |
| Beijing Biostar Pharmaceuticals | 1.68B |
| Guangzhou Innogen Pharmaceutical Group | 1.64B |
| SinoMab BioScience | 1.59B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.35B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.34B |
| Zhaoke Ophthalmology | 1.24B |
| JW (Cayman) Therapeutics Co. | 1.15B |